Almirall jumps after Q1 beat, guidance confirmation

Almirall

13/05/2024 08:42

** Shares in Almirall  ALM.MC  jump around 7% after the
Spanish pharmaceutical company reported Q1 beat and stuck to its
full-year guidance
    ** Sabadell analyst expects a positive share reaction saying
EBITDA came above expectations at 53 million euros vs consensus
of 48 million euros, driven by better evolution in sales and
margins
    ** Jefferies analysts also note a 3% beat on sales, with key
products Ilumetri, Wynzora and Ebglyss ahead 
    ** Almirall said it is on track to meet its 2024 full-year
EBITDA target and added it seeks "new inorganic growth
opportunities"
    ** If gains hold, the stock will see its best day since
February 2022; including Monday's rise it has gained 15% YTD
    ** Shares at the top of Spanish blue chip IBEX35  .IBEX 
index​
    
    
    

 (Reporting by Joao Manuel Mauricio)
 ((JoaoManuel.VicenteMauricio@thomsonreuters.com))